NCT02188719 Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Status TERMINATED Phase PHASE1
NCT02155920 Everolimus for Children With Recurrent or Progressive Ependymoma Status COMPLETED Phase PHASE2
NCT02152943 Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients Status COMPLETED Phase PHASE1
NCT02143726 Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02138929 LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma Status COMPLETED Phase PHASE1
NCT02137837 S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Status TERMINATED Phase PHASE3
NCT02134899 The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients Status COMPLETED Phase PHASE3
NCT02134288 Belatacept for Renal Transplant Recipients With Delayed Graft Function Status TERMINATED Phase EARLY_PHASE1
NCT02125084 Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT02123823 BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT02120469 Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT02115113 REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy Status COMPLETED Phase PHASE3
NCT02106507 ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate Status COMPLETED Phase PHASE1
NCT02091973 MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation Status UNKNOWN Phase NA
NCT02084446 Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant Status COMPLETED Phase PHASE4
NCT02081755 Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer Status ENROLLING_BY_INVITATION Phase PHASE4
NCT02077933 Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors Status COMPLETED Phase PHASE1
NCT02077556 Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients Status COMPLETED Phase PHASE4